BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1028269)

  • 1. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    Trans Am Neurol Assoc; 1976; 101():45-7. PubMed ID: 1028269
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    N Engl J Med; 1976 Dec; 295(26):1455-7. PubMed ID: 995142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid.
    Cohen SR; Brooks BR; Herndon RM; McKhann GM
    Ann Neurol; 1980 Jul; 8(1):25-31. PubMed ID: 6157350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
    Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
    Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
    Lisak RP; Zweiman B
    N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease.
    Yanagisawa K; Quarles RH; Johnson D; Brady RO; Whitaker JN
    Ann Neurol; 1985 Oct; 18(4):464-9. PubMed ID: 2416268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The visual system in myelin disorders. Clinical chemistry and cytology (blood, urine, cerebrospinal fluid).
    Lowenthal A
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():233-6. PubMed ID: 6675811
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of the biochemical pattern of demyelinization in the cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Matías-Guiu J; Martínez-Vázquez JM; Ruibal A; Codina-Puiggrós A
    Med Clin (Barc); 1986 Nov; 87(14):582-4. PubMed ID: 3784678
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelin in normal and diseased states.
    Baumann N; Jacque C; Hauw JJ
    Neurol Clin; 1983 Aug; 1(3):701-27. PubMed ID: 6209539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of myelin basic protein and creatin kinase BB as index of active demyelination.
    Matias-Guiu J; Martinez-Vazquez JM; Ruibal A; Codina A
    Acta Neurol Scand; 1986 Feb; 73(2):203-7. PubMed ID: 2422866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
    Whitaker JN; Lisak RP; Bashir RM; Fitch OH; Seyer JM; Krance R; Lawrence JA; Ch'ien LT; O'Sullivan P
    Ann Neurol; 1980 Jan; 7(1):58-64. PubMed ID: 6153879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',3'-Cyclic nucleotide 3'-phosphodiesterase activity in the cerebrospinal fluid of patients with demyelinating diseases.
    Suda H; Hosokawa T; Ohno R; Hamaguchi K; Tsukada Y
    Neurochem Pathol; 1984; 2(2):85-102. PubMed ID: 6085771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal-fluid changes in demyelinating disorders.
    N Engl J Med; 1977 Apr; 296(15):883-4. PubMed ID: 846503
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram].
    Limongi JC; Machado LR; Spina-França A
    Arq Neuropsiquiatr; 1981 Sep; 39(3):296-300. PubMed ID: 6119970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG; Catz I
    Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase in human cerebrospinal fluid.
    Banik NL; Mauldin LB; Hogan EL
    Ann Neurol; 1979 Jun; 5(6):539-41. PubMed ID: 224801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
    Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.